SCHEMBL4757378

SCHEMBL4757378

CS(=O)(=O)Nc1sc(NC(=O)c2ccccc2O)nc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.55
RAB9A P51151 8/20 0.55
MEN1 O00255 8/20 0.55
KMT2A Q03164 8/20 0.55
RXFP1 Q9HBX9 1/20 0.55
HTT P42858 6/20 0.49
ALDH1A1 P00352 5/20 0.49
KDM4E B2RXH2 4/20 0.49
HPGD P15428 4/20 0.49
TP53 P04637 4/20 0.49
HSD17B10 Q99714 4/20 0.49
GAA P10253 2/20 0.49
RCE1 Q9Y256 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
STAT3 P40763 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 1/20 0.41
LMNA P02545 4/20 0.40
FADS1 O60427 1/20 0.40
KCNMA1 Q12791 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756535 0.83 RAB9A (0.57) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL4757394 0.76 NPC1 (0.64) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL4757379 0.76 STAT3 (0.56) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL4756657 0.74 RAB9A (0.59) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL4756512 0.74 RAB9A (0.70) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL24073821 0.73 RAB9A (0.51) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL31426452 0.70 STAT3 (0.58) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL704075 0.70 STAT3 (0.58) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL703934 0.70 NPC1 (0.67) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL4757405 0.69 MEN1 (0.46) NPC1RAB9AMEN1KMT2ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC NPC1 585/4885RAB9A 1694/4885MEN1 4564/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC NPC1 585/4885RAB9A 1694/4885MEN1 4564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.